C.D.C. Scales Back Recommendations for R.S.V. Vaccine
In an unusual move, federal health officials narrowed their recommendations for who should receive the vaccine against the respiratory syncytial virus. The Centers for Disease Control and Prevention advised last year that adults age 60 or older could receive a single lifetime dose of an R.S.V. vaccine, in consultation with their health care providers. On…